Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension

• Hoofdauteurs: O. B. Kuzmin (Auteur), N. V. Buchneva (Auteur), V. V. Belyanin (Auteur), V. V. Zhezha (Auteur), M. V. Stolbova (Auteur)
• Formaat: Boek
• Gepubliceerd in: Столичная издательская компания, 2024-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Resistant arterial hypertension is characterized by failure to control target blood pressure despite long-term use of optimal or maximum tolerated doses of three different antihypertensive drugs, including diuretic. Patients with resistant hypertension are included in a group of people at high risk...